This announcement is a separate document:
ネクセラファーマ：神経疾患を対象としたコラボレーションが研究開発の最初のマイルストーンを達成したため、Nxera Pharmaはアッヴィから1,000万米ドルを受け取りました
Nxera Pharma: Due to the collaboration targeting neurological disorders achieving the first milestone of research and development, Nxera Pharma received 10 million US dollars from Abbvie.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated